渣打香港遞交首批九成信貸擔保計劃客戶申請
渣打香港公布,支持及配合政府的中小企紓困措施,並已成功向香港按證保險有限公司遞交首批中小企融資擔保計劃下九成信貸擔保計劃的客戶申請。
渣打香港表示,由即日起,所有成功申請中小企融資擔保計劃下九成信貸擔保產品的渣打中小企業客戶,可享減免全期擔保費50%,金額最高達5萬元及豁免貸款手續費,並可享最長5年還款期。申請企業無需提交公司財務報表,簡化申請手續,讓中小企業,特別是小微企業也可受惠,更快取得資金作周轉。
同時,初創企業、「拓展易」中小企業分期貸款、「中小企融資擔保計劃」及「中小企業信貸保證計劃」客戶,可獲豁免全數戶口管理費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.